Compare PASG & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PASG | HHS |
|---|---|---|
| Founded | 2017 | 1923 |
| Country | United States | United States |
| Employees | 27 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.0M | 21.2M |
| IPO Year | 2020 | 1994 |
| Metric | PASG | HHS |
|---|---|---|
| Price | $7.83 | $2.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $23.50 | N/A |
| AVG Volume (30 Days) | ★ 30.3K | 1.9K |
| Earning Date | 05-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $185,242,000.00 |
| Revenue This Year | N/A | $6.54 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.28 | $2.33 |
| 52 Week High | $20.00 | $5.39 |
| Indicator | PASG | HHS |
|---|---|---|
| Relative Strength Index (RSI) | 37.40 | 45.60 |
| Support Level | $6.71 | $2.78 |
| Resistance Level | $7.72 | $2.86 |
| Average True Range (ATR) | 0.77 | 0.07 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 16.73 | 30.23 |
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.